Singapore will review its patent and copyright laws to comply with new regulations under the international agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), a government minister has said.
The Minister for Trade and Industry, Yeo Cheow Tong, said earlier this month that an inter-ministerial committee has been set up to "examine the TRIPS agreement and review what Singapore needs to do to conform to its obligations under TRIPS."
Mr Yeo made the comments to journalists after performing the ground-breaking ceremony of a new S$300 million ($215.8 million) plant of the US pharmaceutical company Schering-Plough. "As part of the completion of the TRIPS agreement, there are several new requirements with which we have to comply," he said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze